Investigation of the Effects of MicroRNA-221 Expression Levels in Glioblastoma Multiforme Tumors
dc.contributor.author | Ozdogan, Selcuk | |
dc.contributor.author | Yaltirik, Cumhur Kaan | |
dc.contributor.author | Yilmaz, Seda Gulec | |
dc.contributor.author | Akdeniz, Fatma Tuba | |
dc.contributor.author | Sumerkent, Kadir | |
dc.contributor.author | Duzkalir, Ali Haluk | |
dc.contributor.author | Ture, Ugur | |
dc.date.accessioned | 2024-03-13T10:33:08Z | |
dc.date.available | 2024-03-13T10:33:08Z | |
dc.date.issued | 2020 | |
dc.department | İstanbul Beykent Üniversitesi | en_US |
dc.description.abstract | Background/Aim: The aim of our study was to examine miRNA-221 as a candidate biomarker to define prognosis and/or classification for glial tumors. Materials and Methods: This study included 39 patients who underwent glial tumor surgery and 40 healthy individuals as the control group. miRNA expression levels were determined by real-time polymerase chain reaction (RT-PCR). Receiver operating characteristic curve analysis was used for analyzing the predictive ability of miRNA-221. Results: The levels of miRNA-221 expression were determined by comparing the Delta CT values of miRNAs and the internal control. When the expression levels of miRNA-221 were compared according to the Delta CT method, miRNA-221 was found to be significantly increased in the patient group compared to the control group (p<0.0001). Conclusion: Increased expression levels of miRNA-221 could be a biomarker for glial tumors. | en_US |
dc.identifier.doi | 10.21873/anticanres.14308 | |
dc.identifier.endpage | 3270 | en_US |
dc.identifier.issn | 0250-7005 | |
dc.identifier.issn | 1791-7530 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 32487621 | en_US |
dc.identifier.scopus | 2-s2.0-85085909824 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 3265 | en_US |
dc.identifier.uri | https://doi.org/10.21873/anticanres.14308 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12662/3795 | |
dc.identifier.volume | 40 | en_US |
dc.identifier.wos | WOS:000538104800027 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Int Inst Anticancer Research | en_US |
dc.relation.ispartof | Anticancer Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Glial tumors | en_US |
dc.subject | glioblastoma | en_US |
dc.subject | microRNA | en_US |
dc.subject | miRNA-221 | en_US |
dc.subject | biomarker | en_US |
dc.title | Investigation of the Effects of MicroRNA-221 Expression Levels in Glioblastoma Multiforme Tumors | en_US |
dc.type | Article | en_US |